Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section reorganized; New Jersey, New York, and Pennsylvania entries are consolidated under a general Locations heading, and the HHS Vulnerability Disclosure link was removed; the revision updated to v3.3.3.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision badge updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedRemoved the government funding operating status notice from the page. The notice previously informed users that information may not be up to date due to funding and system outages.SummaryDifference0.3%

- Check63 days agoChange DetectedExternal informational links to MedlinePlus, NIH/NLM/NCBI, MSKCC, and government sites were removed from the page. These links were supplementary and not part of the core study details.SummaryDifference0.5%

- Check92 days agoChange DetectedCore content updated with an operational status notice and a new version (v3.2.0); previous version (v3.1.0) removed.SummaryDifference3%

- Check99 days agoChange DetectedMajor contact/name and metadata updates: old contact David Pfister, MD and older revision/date replaced with Eric Sherman, MD and new contact numbers, plus updated last-update and revision version.SummaryDifference1%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.